Cargando…

ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia

Detalles Bibliográficos
Autores principales: Joshi, Sunil K., Keck, Jamie M., Eide, Christopher A., Bottomly, Daniel, Traer, Elie, Tyner, Jeffrey W., McWeeney, Shannon K., Tognon, Cristina E., Druker, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515826/
https://www.ncbi.nlm.nih.gov/pubmed/32366937
http://dx.doi.org/10.1038/s41375-020-0844-7
_version_ 1783586882381152256
author Joshi, Sunil K.
Keck, Jamie M.
Eide, Christopher A.
Bottomly, Daniel
Traer, Elie
Tyner, Jeffrey W.
McWeeney, Shannon K.
Tognon, Cristina E.
Druker, Brian J.
author_facet Joshi, Sunil K.
Keck, Jamie M.
Eide, Christopher A.
Bottomly, Daniel
Traer, Elie
Tyner, Jeffrey W.
McWeeney, Shannon K.
Tognon, Cristina E.
Druker, Brian J.
author_sort Joshi, Sunil K.
collection PubMed
description
format Online
Article
Text
id pubmed-7515826
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75158262020-10-02 ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia Joshi, Sunil K. Keck, Jamie M. Eide, Christopher A. Bottomly, Daniel Traer, Elie Tyner, Jeffrey W. McWeeney, Shannon K. Tognon, Cristina E. Druker, Brian J. Leukemia Letter Nature Publishing Group UK 2020-05-04 2020 /pmc/articles/PMC7515826/ /pubmed/32366937 http://dx.doi.org/10.1038/s41375-020-0844-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Joshi, Sunil K.
Keck, Jamie M.
Eide, Christopher A.
Bottomly, Daniel
Traer, Elie
Tyner, Jeffrey W.
McWeeney, Shannon K.
Tognon, Cristina E.
Druker, Brian J.
ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
title ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
title_full ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
title_fullStr ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
title_full_unstemmed ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
title_short ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
title_sort erbb2/her2 mutations are transforming and therapeutically targetable in leukemia
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515826/
https://www.ncbi.nlm.nih.gov/pubmed/32366937
http://dx.doi.org/10.1038/s41375-020-0844-7
work_keys_str_mv AT joshisunilk erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia
AT keckjamiem erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia
AT eidechristophera erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia
AT bottomlydaniel erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia
AT traerelie erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia
AT tynerjeffreyw erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia
AT mcweeneyshannonk erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia
AT tognoncristinae erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia
AT drukerbrianj erbb2her2mutationsaretransformingandtherapeuticallytargetableinleukemia